Special Issue

The Role of Matrix Metalloproteinases in Human Diseases

Submission Deadline: 30 Jun 2024

Guest Editor

  • Portrait of Guest Editor Raffaele  Serra

    Raffaele Serra MD, PhD

    Department of Medical and Surgical Science, University Magna Graecia of Catanzaro, Catanzaro, Italy

    Interests: wound healing; vascular surgery; metabolic syndrome; treatment; vascular medicine; reconstructive surgery; general surgery; surgery; diabetes; atherosclerosis

Special Issue Information

Dear Colleagues,

Matrix metalloproteinases (MMPs) play an important role in tissue remodeling during various physiological processes, such as embryogenesis, morphogenesis, angiogenesis, and wound repair. There are other metalloproteinases linked to MMPs, such as members of the families A Disintegrin and Metalloproteinase (ADAM) and A Disintegrin and Metalloproteinase with Thrombospondin motifs (ADAMTS), that work within the extracellular matrix (ECM).

Metalloproteinases are inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs), which are endogenous protein regulators of the ECM.

When the expression of metalloproteinases is altered, it can generate the abnormal degradation of the ECM. This is the initial cause of the development of chronic degenerative diseases such as cardiovascular disease, chronic wounds, cancer, and inflammatory disorders. The exact physiological and biological mechanism of metalloproteinases and the details of their clinical implication and regulation by other molecules are not completely known. Therefore, this Special Issue welcomes original and review articles that can improve our understanding of these issues.

Prof. Dr. Raffaele Serra

Guest Editor

Keywords

  • MMPs
  • ADAM
  • ADAMTS
  • ECM
  • cardiovascular disease
  • cancer
  • chronic wounds
  • inflammatory disorders
  • chronic disease

Published Paper (1)

Open Access Review
785
398
22